- Stock Of The Day Lilly Nears A Record — Again — As It Enters The Obesity Arena Investor’s Business Daily
- Mounjaro, Zepbound: Why two names for the same drug? STAT
- Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock? The Motley Fool
- FDA approves new obesity drug Zepbound to compete with Wegovy Diabetes.co.uk
- Novel obesity treatments CMAJ
- View Full Coverage on Google News